Clinical Outcomes of Angioplasty Postconditioning

Sponsor
Hospices Civils de Lyon (Other)
Overall Status
Completed
CT.gov ID
NCT00419198
Collaborator
(none)
91
1
2
39
2.3

Study Details

Study Description

Brief Summary

We previously demonstrated that postconditioning by coronary angioplasty can decrease infarct size (as measured by cardiac enzyme release) in patients with ongoing acute myocardial infarction. It is currently unknown whether postconditioning actually decreases or simply delays myocardial cell death during reperfusion. In addition, the long term effects of postconditioning on recovery of myocardial contraction remains elusive. The objective of the present study is to determine whether infarct size reduction by angioplasty postconditioning is maintained at 6 months and whether functional recovery is improved at one year post-infarction.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Postconditioning
  • Procedure: standard angioplasty
N/A

Detailed Description

Randomized, controlled, single-blinded trial comparing postconditioning to control (no intervention). Postconditioning consists of four episodes of one minute inflation followed by one minute deflation of the angioplasty balloon, starting within one minute of reflow after direct stenting of the occluded coronary artery.

Study Design

Study Type:
Interventional
Actual Enrollment :
91 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Diagnostic
Official Title:
Postconditioning and Functional Recovery After Acute Myocardial Infarction
Study Start Date :
Sep 1, 2005
Actual Primary Completion Date :
Mar 1, 2008
Actual Study Completion Date :
Dec 1, 2008

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Post-conditioning during angioplasty

Procedure: Postconditioning
Postconditioning during angioplasty

Active Comparator: 2

standard angioplasty

Procedure: standard angioplasty
standard angioplasty without postconditioning

Outcome Measures

Primary Outcome Measures

  1. Infarct size as measured by cardiac enzymes and MRI at day 5 to 7 [during 72 hours after angioplasty, and at day 5 to 7]

Secondary Outcome Measures

  1. Myocardial contraction (LV ejection fraction, wall motion score index, strain rate) measured by echocardiography at 6 month. [at 6 month]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male and female patients, aged more than 18, with suspected first acute myocardial infarction, within 6 hours of the onset of chest pain, with a need for emergency revascularization by angioplasty. Patients must display a fully occluded (TIMI zero flow) culprit coronary artery, absence of visible collaterals and exhibit TIMI flow >2 after direct stenting by angioplasty.
Exclusion Criteria:
  • Cardiac arrest or cardiogenic shock

  • occlusion of the circumflex coronary artery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Michel Ovize Lyon France 69677

Sponsors and Collaborators

  • Hospices Civils de Lyon

Investigators

  • Principal Investigator: michel Ovize, MD, Hospices Civils de Lyon

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00419198
Other Study ID Numbers:
  • 2004.364
First Posted:
Jan 8, 2007
Last Update Posted:
May 28, 2019
Last Verified:
Mar 1, 2010
Keywords provided by , ,
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 28, 2019